⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2024Open Access

Table S5 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors

B. Leticia Rodriguez Jiawei Huang Laura Gibson Jared J. Fradette Hung-I Harry Chen Kikuye Koyano Czrina Cortez Betty Li Carmence Ho Amir M. Ashique Vicky Y. Lin Suzanne Crawley Julie M. Roda Peirong Chen Bin Fan Jeong Kim James Sissons Jonathan Sitrin Daniel D. Kaplan Don L. Gibbons Lee B. Rivera

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

NGM438 binding to cell-expressed LAIR1.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rodriguez et al. (2024) studied this question.

synapsesocial.com/papers/68e5e0e0b6db643587574b0a https://doi.org/10.1158/1535-7163.26423797.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S5 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors2024
2Table S1 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors2024
3Table S1 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors2024
4Table S3 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors2024
5Table S3 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors2024

Figure S1 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors2024
Figure S2 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors2024
Table S2 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors2024